Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Agex Therapeutics Inc (AGE)

Agex Therapeutics Inc (AGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Agex Therapeutics Inc 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 USA

www.agexinc.com P: 510-671-8370

Description:

AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics Inc. is based in Alameda, United States.

Key Statistics

Overview:

Market Capitalization, $K 11,964
Enterprise Value, $K 11,614
Shares Outstanding, K 1,078
Annual Sales, $ 140 K
Annual Net Income, $ -14,800 K
Last Quarter Sales, $ 60 K
Last Quarter Net Income, $ -3,460 K
EBIT, $ -9,970 K
EBITDA, $ -4,550 K
60-Month Beta 1.18
% of Insider Shareholders 6.50%
% of Institutional Shareholders 12.50%
Float, K 1,008
% Float 93.50%
Short Volume Ratio 0.45

Growth:

1-Year Return -52.30%
3-Year Return -82.44%
5-Year Return -93.47%
5-Year Revenue Growth -90.00%
5-Year Earnings Growth -85.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.93 on 11/14/23
Latest Earnings Date 05/10/24
Earnings Per Share ttm -10.56
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -133.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 7-250 on 03/15/24

AGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -120.90%
Profit Margin % -10,571.43%
Debt/Equity 0.00
Price/Sales 95.64
Price/Cash Flow N/A
Price/Book 2.53
Book Value/Share 4.96
Interest Coverage -2.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar